BIELLA, FABIO
BIELLA, FABIO
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Cholesterol as a synaptogenic factor involved in the development of proper synaptic structure in an hiPSC-derived neurons model of Rett syndrome
2025 F. Biella, F.M. Postogna, N. Giancroce, O.M. Roggero, N. Landsberger, A. Frasca
Cholesterol dysregulation in Rett syndrome: implications for synaptic function
2025 F. Postogna, M. Breccia, O. Roggero, F. Biella, C. Cabasino, A. Arcari, N. Giancroce, N. Landsberger, A. Frasca
Role of IL-6 in Rett syndrome: from in vitro findings to in vivo therapeutic target validation
2025 O. Roggero, M. Breccia, F. Postogna, F. Biella, N. Landsberger, E. Boda, A. Frasca
Role of IL-6 in Rett syndrome: from in vitro findings to in vivo therapeutic target validation
2025 O. Roggero, M. Breccia, F. Biella, F. Postogna, E. Boda, A. Frasca
Cholesterol dysregulation in Rett syndrome: implications for synaptic function
2025 F. Postogna, F. Biella, O. Roggero, N. Giancroce, M. Valenza, A. Frasca
Interpreting the rich dialogue between astrocytes and neurons: An overview in Rett syndrome
2025 F.M. Postogna, O.M. Roggero, F. Biella, A. Frasca
Role of interleukin 6 in the pathogenesis of Rett syndrome: focus on astrocyte-neuron crosstalk and its therapeutic implication
2024 O. Roggero, M. Breccia, F. Biella, F. Postogna, N. Landsberger, A. Frasca
Reduction in cholesterol supply by Mecp2 null astrocytes contributes to synaptic defects
2024 F. Postogna, M. Breccia, O. Roggero, F. Biella, E. Albizzati, C. Cabasino, A. Arcari, D. Colombo, L. Morelli, E. Chiricozzi, N. Landsberger, A. Frasca
Case report: Dihydropyridine receptor (CACNA1S) congenital myopathy, a novel phenotype with early onset periodic paralysis
2024 S.K. Aburahma, L.A. Rousan, M. Shboul, F. Biella, S. Lucchiari, G.P. Comi, G. Meola, S. Pagliarani
Soft cerebellar signs unveil RARS2‐related epilepsy
2024 V. Yahya, R. Dilena, R. DEL BO, M. Magni, F. Biella, S. Salani, F. Fortunato, E. Scola, A. Di Fonzo, E. Monfrini
Whole-Exome Sequencing Study of Fibroblasts Derived From Patients With Cerebellar Ataxia Referred to Investigate CoQ10 Deficiency
2023 E. Monfrini, A. Pesini, F. Biella, C.F.R. Sobreira, V. Emmanuele, G. Brescia, L.C. Lopez, S. Tadesse, M. Hirano, G.P. Comi, C.M. Quinzii, A. Di Fonzo
Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
2022 M. Rizzuti, V. Melzi, D. Gagliardi, D. Resnati, M. Meneri, L. Dioni, P. Masrori, N. Hersmus, K. Poesen, M. Locatelli, F. Biella, R. Silipigni, V. Bollati, N. Bresolin, G.P. Comi, P. Van Damme, M. Nizzardo, S. Corti
C9orf72 ALS Human Neural Organoids for the Development of New Therapeutics and Disease Modeling
2021 G. Costamagna, F. Biella, I. Faravelli, M. Nizzardo, R. Brusa, G.P. Comi, N. Bresolin, S.P. Corti
Morpholino oligomers ameliorates pathological hallmarks in C9orf72 cellular lines and mice
2021 M. Bersani, D. Gagliardi, M. Taiana, F. Biella, M. Nizzardo, S. Corti
Human spinal cord-like organoids to model C9ORF72 ALS and test new therapies in vitro
2021 G. Costamagna, N. Galli, M. Rizzuti, B. Frizzi, F. Biella, M. Taiana, S. Ghezzi, I. Faravelli, G.P. Comi, M. Nizzardo, S. Corti
INVESTIGATION OF C9ORF72 MOLECULAR HALLMARKS AND DEVELOPMENT OF THERAPEUTIC STRATEGIES
2021 F. Biella
A novel homozygous VPS11 variant may cause generalized dystonia
2021 E. Monfrini, F. Cogiamanian, S. Salani, L. Straniero, G. Fagiolari, M. Garbellini, E. Carsana, L. Borellini, F. Biella, M. Moggio, N. Bresolin, S. Corti, S. Duga, G.P. Comi, M. Aureli, A. Di Fonzo
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia
2020 D. Gagliardi, G. Costamagna, M. Taiana, L. Andreoli, F. Biella, M. Bersani, N. Bresolin, G.P. Comi, S. Corti
Evaluation of Morpholino oligomers therapeutic efficacy in C9orf72 ALS iPSC-derived lines
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, N. Bresolin, G.P. Comi, S. Corti
Changes in pathological phenotype of C9orf72 ALS iPSC-derived lines after treatment with Morpholino oligomers
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, S. Corti